RxDoctor Payments Data

Diem My Bui, OD

Optometrist · Morrow, GANPI 1801449350

Payments from drug & device makers

$1,695in general payments, 2019–2025

Across 79 payments — averaging $21.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Oyster Point Pharma, Inc.$248
  • Alcon$222
  • Bausch & Lomb Americas Inc.$211
  • Glaukos Corporation$210
  • AbbVie$194
  • Sun Pharmaceutical Industries Inc.$154
  • plus $456 from 11 others

What the payments were for

  • Food & beverage$1,695100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,695 in reported general payments places this provider in the 65th percentile of 1,285 optometrist providers in Georgia.

See all optometrist providers in Georgia

Medicare billing

Part B allowed, 2024
$36,990
Medicare patients
299
Services billed
480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine119$186,753
XiidraLifitegrast79$124,452
Cyclosporine38$18,630
LumiganBimatoprost21$14,513
SimbrinzaBrinzolamide/Brimonidine Tart21$5,489
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol13$3,818
Latanoprost256$3,226
Loteprednol Etabonate19$2,946
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha27$312
Timolol Maleate55$272
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat14$165
Azithromycin13$31

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieRestasis, Lumigan$194$201,267140 claims
Bausch & Lomb Americas Inc.Xiidra$211$124,45279 claims
AlconSimbrinza$222$5,48921 claims
Bausch & Lomb, A Division Of Bausch Health US, LLCLoteprednol Etabonate$30$2,94619 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,285 optometrist providers in Georgia.

Other optometrist in Morrow

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →